ITGAM + Extracellular Vesicles Trigger CD8 + T Cell Activation via S100a9‐Mediated Metabolic Reprogramming in Acute Kidney Injury
Journal of Extracellular Vesicles · 2026-11 · 15 (11)
DOI: 10.1002/jev2.70404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 05.11.2026. Verfasst von Yu-Qi Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nephrology, Jiangsu Provincial Key Laboratory of Renal Injury and Repair, Zhongda Hospital, Southeast University School of Medicine, Nan…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Calgranulin B, CD8-Positive T-Lymphocytes, Extracellular Vesicles. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Outstanding Physician, Jiangsu Provincial Innovation Center for Nephrology Project.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a prevalent condition with limited therapeutic options, in which sustained renal injury driven by inflammation remains a central pathological challenge. Here, we identify a specific subset of extracellular vesicles (EVs) as the critical link translating early myeloid inflammation into metabolically fuelled CD8 + T cell pathogenicity. Using single‐EV surface proteomics via a proximity barcoding assay in a murine ischemia‐reperfusion injury model, we mapped the renal EV landscape and discovered a myeloid‐derived ITGAM + EV subset with markedly increased abundance after injury. Using a CD63‐PAGFP ITGAM‐KI reporter mouse that genetically enhances ITGAM + EV release, we further validated that these EVs interact with CD8 + T cells in the renal lymphatic niche, driving their pro‐inflammatory activation. Proteomic profiling pinpointed S100a9 as the functional cargo on these ITGAM + EVs. Mechanistically, EV‐delivered S100a9 stabilized the mitochondrial aspartate‐glutamate carrier Slc25a12 in recipient CD8 + T cells, thereby enhancing glutamate metabolism to fuel a pathogenic transcriptional program. Pharmacological inhibition of S100a9 with tasquinimod, combined with genetic loss of S100a9 in bone marrow‐derived myeloid cells, established the necessity of EV‐associated S100a9 in driving CD8 + T cell activation. Our findings establish ITGAM + EVs as essential mediators of pro‐metabolic and pro‐inflammatory signal in AKI and highlight the S100a9–Slc25a12 axis as a promising therapeutic target for intercepting sterile inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Nephrology, Jiangsu Provincial Key Laboratory of Renal Injury and Repair, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Yu-Qi Fu, An-Ran Shen, Min Wu, Bin Wang, Lin-Li Lv, Bi-Cheng Liu
Förderung
- National Natural Science Foundation of China
- National Outstanding Physician
- Jiangsu Provincial Innovation Center for Nephrology Project
Zitieren
APA
Fu, Y. Q., Zhang, Y. L., Shen, A. R., Li, N., Song, J., Bao, Y., Wang, S. M., Xue, D. D., Wu, M., Wang, B., Wen, Y., Tang, T. T., Lv, L. L., & Liu, B. C. (2026). ITGAM + Extracellular Vesicles Trigger CD8 + T Cell Activation via S100a9‐Mediated Metabolic Reprogramming in Acute Kidney Injury. Journal of Extracellular Vesicles, 15(11). https://doi.org/10.1002/jev2.70404
Vancouver
Fu YQ, Zhang YL, Shen AR, Li N, Song J, Bao Y, et al. ITGAM + Extracellular Vesicles Trigger CD8 + T Cell Activation via S100a9‐Mediated Metabolic Reprogramming in Acute Kidney Injury. Journal of Extracellular Vesicles. 2026;15(11). doi:10.1002/jev2.70404
BibTeX
@article{Fu2026,
author = {Fu, Yu-Qi and Zhang, Yi-Lin and Shen, An-Ran and Li, Ning and Song, Jing and Bao, Yan and Wang, Si-Meng and Xue, Ding-Ding and Wu, Min and Wang, Bin and Wen, Yi and Tang, Tao-Tao and Lv, Lin-Li and Liu, Bi-Cheng},
title = {ITGAM + Extracellular Vesicles Trigger CD8 + T Cell Activation via S100a9‐Mediated Metabolic Reprogramming in Acute Kidney Injury},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/jev2.70404}
}
EUVIMED